DIABETES RESEARCH CENTERS

Michael Sturek Michael Sturek PhD Indiana University Indiana University
The general aim of our research program is to understand cellular and molecular Ca signaling mechanisms for in vivo cardiovascular phenomena. The mission of the new, integrated Indiana Diabetes Research Center (IDRC) is to foster knowledge, support training, and promote basic and translational research in diabetes and related metabolic disorders, and their complications.
John W Turk John W Turk MD PhD Washington University in St Louis Washington University in St Louis
Dr. John W Turk is a Professor of Medicine in the Division of Endocrinology, Metabolism & Lipid Research at Washington University in St. Louis, and Director of the Mass Spectrometry Resource Core. TThe mission of the Washington University School of Medicine (WUSM) Diabetes Research Center (DRC) is to support and enhance research in diabetes and related metabolic diseases.
James F Markmann MD PhD Boston Area Boston Area
James F. Markmann MD, PhD is the Chief of the Division of Transplant Surgery and Director of Clinical Operations at the Transplant Center at Massachusetts General Hospital, and the Claude Welch Professor of Surgery at Harvard Medical School. The Boston Area Diabetes Endocrinology Research Center is a consortium of laboratory-based and clinical investigators whose efforts are directed toward addressing many of the major research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Steven E Kahn MB ChB University of Washington University of Washington
Dr. Kahn received his medical degree from the University of Cape Town, South Africa. He is an endocrinologist whose research focuses on the mechanisms responsible for the critical impairments in insulin secretion that result in the development of diabetes. The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
Steven E Shoelson Steven E Shoelson MD PhD Joslin Diabetes Center Joslin Diabetes Center
​Steve Shoelson’s laboratory identifies physiological and pathological mechanisms in metabolism with the potential for development of new therapeutics. Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Domenico Accili Domenico Accili MD Columbia University Columbia University
The Accili laboratory studies the mechanism of insulin action and the pathogenesis of diabetes, with a focus on pancreatic beta cell failure. The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
Raimund I Herzog Raimund I Herzog MD MHS Yale University Yale University
Dr. Herzog’s laboratory is focused on characterizing and preventing its central nervous complications. He uses state-of-the-art technologies to define the impact of diabetes and intensive insulin treatment on brain metabolism and cognition. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Stuart J Frank Stuart J Frank MD University of Alabama at Birmingham University of Alabama at Birmingham
The focus of research in my laboratory is in understanding mechanisms of action of growth hormone (GH), an important metabolic and growth promoting hormone. The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Jill P Crandall Jill P Crandall MD Albert Einstein College of Medicine Albert Einstein College of Medicine
Dr. Crandall is Director of the Diabetes Clinical Trials Unit and co-director of the DRTC Clinical Research Facilitation Core. She is an experienced clinical investigator with a joint appointments in the Divisions of Endocrinology and Geriatrics. The Einstein-Mount Sinai Diabetes Research Center (ES-DRC) comprises a vibrant, extensive, diverse, well-funded and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism and endocrinology.
Manami Hara Manami Hara PhD University of Chicago University of Chicago
Dr. Hara's research focuses on the identification and characterization of the cells that define the lineage that gives rise to the pancreatic beta cell. The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Pietro De Camilli Pietro De Camilli MD Yale University Yale University
The De Camilli lab is interested in the cell biology of neuronal synapses. His studies on synaptic vesicle dynamics have contributed to the general fields of exocytosis and, more recently, of endocytosis. The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Paul Harris Paul Harris PhD Columbia University Columbia University
Dr. Harris' research interests are in the non-invasive measurements of pancreatic insulin-producing cell (beta cell) mass using PET scan in type 1 diabetes and in other forms of diabetes. The Columbia University Diabetes and Endocrinology Research Center provides research support for investigators pursuing research on diabetes and metabolic disorders.
William Herman William Herman MD University of Michigan University of Michigan
Dr. William Herman received his medical degree from Boston University in 1979. He completed an internship and residency in Internal Medicine at the University of Michigan. Dr Herman's past and present research has focused on clinical, epidemiologic, and health services research in diabetes. The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
Qizhi Tang Qizhi Tang PhD UCSF UCSF
The Tang lab focuses on translating knowledge on mechanisms of immune tolerance into novel therapeutics for treating autoimmune diabetes and preventing transplant rejection. The UC San Francisco (UCSF) Diabetes Research Center (DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Hsin-Chieh (Jessica) Yeh Hsin-Chieh (Jessica) Yeh PhD Johns Hopkins University - University of Maryland Johns Hopkins University - University of Maryland
Dr. Yeh is an epidemiologist and Associate Professor in the Division of General Internal Medicine at Johns Hopkins School of Medicine with expertise on cohort studies and clinical trials of lifestyle factors, obesity, cancer, and diabetes. The Johns Hopkins University - University of Maryland Diabetes Research Center fosters collaborative, multidisciplinary diabetes and endocrinology research, and translates that research into programs that advance the diagnosis and management of diabetes mellitus by health care professionals.
Jerome I. Rotter MD UCSD-UCLA UCSD-UCLA
Jerome I. Rotter is Director of Research and Co-Director of the Medical Genetics Institute, Director of the Division of Medical Genetics (Department of Medicine) and Director of the Common Diseases Genetics Program at Cedars-Sinai. The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.

Diabetes Centers Overview

Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.

In the Spotlight

Pilot & Feasibility Study
Center Publication
Washington University in St Louis WUSTL 
Intermittent fasting preserves beta-cell mass in obesity-induced diabetes via the autophagy-lysosome pathway., Liu, Haiyan, Javaheri Ali, Godar Rebecca J., Murphy John, Ma Xiucui, Rohatgi Nidhi, Mahadevan Jana, Hyrc Krzysztof, Saftig Paul, Marshall Connie, et al. , Autophagy, 2017, Volume 13, Issue 11, p.1952-1968, (2017)
NIDDK Center
The Nutrition Obesity Centers integrate, coordinate, and foster interdisciplinary basic, clinical, and public health research by established investigators actively conducting programs of high-quality research related to common nutritional sciences and/or obesity theme or themes.
Diabetes Resource
ImmPort is a long-term, sustainable data warehouse for the purpose of promoting re-use of immunological data generated by NIAID DAIT and DMID funded investigators. ImmPort supports analysis of flow cytometry results and HLA genetic associations.